This compound is a nucleoside protecting group intermediate used in pharmaceutical manufacturing. It features a uracil base linked to a bicyclic sugar core with two silyl protecting groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
N-Acetyl-5'-O-[bis(4-methoxyphenyl)(phenyl)methyl]-2'-O-[tert-butyl(dimethyl)silyl]cytidine
pharmaceutical intermediate
L-Isoleucine tert-butyl ester hydrochloride
pharmaceutical intermediate
2,6-Dibromotoluene
pharmaceutical intermediate
2-benzylaminopyridine
pharmaceutical intermediate
3-(2-Chloro-6-fluorophenyl)-5-methylisoxazole-4-carbonyl chloride
pharmaceutical intermediate
1-[(6aR,8R,9R,9aS)-9-hydroxy-2,2,4,4-tetra(propan-2-yl)-6a,8,9,9a-tetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl]pyrimidine-2,4-dione
KKLQDUCRZCCKHG-VBSBHUPXSA-N
CC(C)[Si]1(OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC(=O)NC3=O)O)O[Si](O1)(C(C)C)C(C)C)C(C)C
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.